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Introduction
            Wide complex tachycardia (WCT) refers to a cardiac rhythm of more than 100 beats per 
minute with a QRS duration of 120 ms or more on the surface electrocardiogram (ECG). It often 
presents a diagnostic dilemma for the physician particularly in determining its site of origin, 
which can be ventricular or supraventricular. In one series, only 32% of clinicians correctly 
diagnosed ventricular tachycardia (VT) in patients who presented with WCT1. Prompt diagnosis 
of the etiology of WCT is, however, essential since immediate care is frequently required. 
Diagnostic and therapeutic errors can produce poor outcome especially when ventricular 
tachycardia   is   not   recognized.2,3                                                                               
             WCT that is grossly irregular typically represents atrial fibrillation with aberrant 
conduction or preexcitation. If its rate exceeds 200 beats per minute, the likelihood of atrial 
fibrillation with conduction over an accessory pathway should be entertained. In this article, we 
will discuss the approach to the evaluation and management of regular WCT.                       
Differential   Diagnosis                                                                                
             The differential diagnosis of regular wide complex tachycardia includes three major 
categories: ventricular tachycardia (VT), supraventricular tachycardia (SVT) with aberrance and 
preexcited   tachycardia.                                                                    
             Ventricular tachycardia is the most common etiology accounting for about 80 % of 
WCT.2-4  Ventricular tachycardia originates from the ventricles and does not require any 
supraventricular tissues for its maintenance. A significant number of patients with VT are 
hemodynamically   stable   and   are   asymptomatic   or   present   with   palpitation   or   mild 
lightheadedness.5 This adds to the dilemma of diagnosing WCT since there is a misconception 
amongst physicians that hemodynamic stability is not consistent with a diagnosis of VT. The 
failure to recognize hemodynamically stable VT can often lead to inappropriate therapy and 
dangerous   sequelae.                                                                        
            SVT with aberrance accounts for a small portion of WCT. SVT typically originates in 
atrial tissue and/or AV junction and utilizes the normal atrioventricular (AV) conduction system 
for ventricular activation. Aberrance occurs when there is delay or block in the His-Purkinje 
system during antegrade conduction of impulses over the normal AV fascicles. Essentially, all 
types of SVT with aberrant conduction can present as a WCT. These include atrial tachycardias, 
atrioventricular nodal reentrant tachycardias, orthodromic reciprocating tachycardias, and other 
rare   forms   of   SVT.                                                            
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 2(4): 120-126 (2002)Patrick Lam, Samir Saba, “Approach to the Evaluation and Management of             121 
Wide Complex Tachycardias”
             Preexcited tachycardias are conducted antegradely over an accessory pathway (AP). 
Evidence for the presence of an AP can be manifest of the surface electrocardiogram (ECG) 
which can show intermittent or continuous presence of a delta wave associated with a short PR 
interval. The delta wave represents the part of the ventricular myocardium that is depolarized 
through   the   AP.                                                                              
             An increasingly recognized cause of WCT is electrographic artifact.6  The clinical 
consequences of misinterpreting artifact as WCT are significant7 and can subject patients to a 
wide range of unnecessary diagnostic and therapeutic procedures including cardiac catherization 
and implantation of cardiac devices.                                                                       
            Ventricular paced rhythms represent a small portion of WCT. Sometimes the bipolar 
ventricular spike is small and difficult to see. The WCT is typically of LBBB pattern and 
superior leftward axis with right ventricular apical pacing. This pattern can vary significantly 
with the site of pacing. The tachycardia can be due to any form of SVT where the pacemaker is 
tracking sensed atrial activity and is pacing the ventricles at a fast rate. It can also represent a 
pacemaker-mediated tachycardia where the pacemaker is tracking retrogradely conducted atrial 
activity during ventricular pacing. A history and physical examination revealing the presence of 
a cardiac implantable device provide important clues to this diagnosis.                      
Clinical Approach to the Differential Diagnosis                                                           
History
         A history of structural heart disease, particularly of coronary artery disease or prior 
myocardial infarction, strongly suggests a diagnosis of VT in patients presenting with WCT.8,9 
The   overall   physical   appearance   of   the   patient,   his   or   her   presenting   symptoms   and 
hemodynamic measurements are generally not very useful.1,2 A history of medications taken by 
the patient, particularly those that are known to have proarrhythmic effects, such as most anti-
arrhythmic drugs, can also help with the discrimination between the various possible etiologies 
of   WCT.                                                                        
Physical   Examination                                                                    
            Although the blood pressure and heart rate are not particularly useful in differentiating 
WCT   of   ventricular   versus   supraventricular   origin,   certain   physical   signs   such   as   the 
demonstration of AV dissociation strongly suggest a diagnosis of VT. These signs include the 
presence of cannon A waves on jugular vein examination, irregular intensity of the first heart 
sound by auscultation, and varying systolic blood pressure. These physical signs are highly 
specific and sensitive for the diagnosis of VT.10 Vagal maneuvers such as carotid sinus massage 
as well as the use of AV nodal blocking agents such as adenosine may cause transient 
ventriculoatrial block leading to AV dissociation that establishes the diagnosis of VT.11 
Although the termination of WCT by physical maneuvers such as carotid sinus massage and 
Valsalva are strongly suggestive of SVT, there are well documented reports of similar 
occurrences in patients with VT.12,13  Termination of WCT by adenosine, digoxin, calcium-
channel blockers, or b-blockers is again strongly suggestive of a diagnosis of SVT. There are 
however well documented cases of similar responses with VT.14,15  Of utmost importance 
however is the avoidance by physicians of medications such as verapamil that can compromise 
the hemodynamic stability of patients with VT. This can lead to the abrupt clinical deterioration 
of an otherwise stable patient and can lead to hazardous consequences.16                    
             An uncommon but sometimes useful semi-invasive procedure in the evaluation of 
patients with WCT is the placement of a transesophageal probe to record the atrial electrical 
activity and establish the diagnosis.17                                                                                            
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The Electrocardiogram  (Figure1, Figure 2)                                                                   
             The ECG remains a cornerstone in the diagnosis of WCT. A plethora of different 
diagnostic criteria have been suggested to distinguish between the various etiologies of WCT, 
each with different sensitivity and specificity.18-21                                                                         
            The most useful ECG criterion in establishing the diagnosis of VT is the presence of AV 
dissociation with more ventricular than atrial events. This practically rules out the possibility of 
the WCT representing an SVT. Fusion beats during WCT also imply the presence of AV 
dissociation,  since  they  are  the  result  of   the  simultaneous  activation  of   the  ventricular 
myocardium through both the normal conduction system and from an ectopic ventricular focus. 
A capture beat, also known as Dressler beat, is a narrow QRS complex resulting from a well-
timed P wave capturing the ventricular myocardium through the normal conduction system 
during VT. A narrow complex beat, however, can also occur during WCT in patients with SVT 
and underlying bundle branch block (BBB). In this case, a ventricular premature beat originating 
from or close to the non-conducting bundle branch fuses with the impulses traveling down the 
contralateral bundle resulting in simultaneous ventricular activation on both sides of the septum 
and in a narrow QRS complex.                                                                                 
            The QRS duration has been proposed as a criterion to differentiate between WCT of 
ventricular and supraventricular origins. Wellens and colleagues found that 69% of VTs had 
QRS duration greater than 140 ms, whereas no SVT had QRS duration in this range.20 This 
criterion was further extrapolated to patients with underlying BBB.2 Ventricular tachycardia was 
the likely diagnosis when the QRS duration was greater than 140 ms in patients with right BBB 
QRS   patterns   and   greater   than   160   ms   in   those   with   left   BBB   QRS   patterns.        
            The cardiac electrical axis during WCT is also useful to determine the origin of the 
abnormal rhythm. In the presence of a right superior (northwest) axis, the WCT is unlikely to 
represent an SVT, since this ECG pattern is inconsistent with any type of typical bundle-branch 
or fascicular block. Also, electrical concordance across the precordium (all QRS complexes 
pointing in the same direction in ECG leads V1 through V6) is rarely consistent with an SVT, 
and typically represents an anteroapical (negative concordance) or a posterobasal (positive 
concordance)   left   ventricular   VT.                                                                        
             Morphology is also often used to differentiate between WCT of ventricular from 
supraventricular origins.19 In the presence of a right BBB QRS pattern in lead V1, the diagnosis 
is likely to be VT if the left QRS peak (R) is taller than the right peak (r') or if the QRS complex 
is biphasic with an Rs or qR pattern. In the presence of a left BBB QRS pattern, VT is the likely 
diagnosis if in lead V1, the duration of the initial r wave is greater than 30 ms, the time from the 
beginning of the QRS to the nadir of the S wave is greater than 70 ms, and if the down stroke of 
the S wave is notched. The morphology of the QRS complex in lead V6  is also used to 
discriminate between SVT and VT. If in lead V6 the QRS complex has a monophasic QS or 
biphasic rS morphology with an r to S ratio < 1 during right BBB WCT, then VT is likely. If the 
intrinsicoid deflection in V6 is greater than 80 ms, then VT is also more likely. All these criteria 
have been clinically evaluated. Their usefulness in the distinction between SVT and VT during 
WCT is limited and not as good as was initially suggested by early reports.22 
Role of Invasive Electrophysiologic Testing 
             In certain situations, patient can have episodes of WCT that may require invasive 
electrophysiologic (EP) testing to make a diagnosis. The primary indication for EP testing in 
patients with WCT is if the correct diagnosis is unclear after analysis of available ECG tracings 
and the knowledge of the correct diagnosis is necessary for patient care. This is listed by the 
American College of Cardiology/American Heart Association task force as a class I indication 
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for performing an EP study23. Class I indications are conditions for which there is evidence 
and/or general agreement that a given procedure or treatment is useful and effective.
 
Figure 1. Wide complex tachycardia in a 45 year old woman with a structurally 
normal heart. This rhythm was incidentally noted on a cardiac monitor during an 
elective surgery. The patient had a similar episode 4 years earlier in the context of 
another elective surgery. She was completely asymptomatic during this rhythm. 
            Note the left bundle, right axis morphology of the QRS complex. The 
width of the QRS complex is 200 milliseconds. The initial r wave in V1 is about 
35 milliseconds in duration. There is a notch on the down stroke of the S wave in 
V1. All these morphologic features point to a diagnosis of VT. There is no 
precordial concordance in ECG leads V1 through V6 however, a feature more 
frequently   seen   in   SVTs.   Adenosine   (12   mg   IV)   failed   to   terminate   the 
tachycardia or change the rhythm. This WCT represents an idiopathic VT 
originating from the right ventricular outflow tract. Paper speed is 25 mm/s.
 
Figure 2. WCT due to an SVT with left BBB aberrance. Note that the tachycardia 
is induced by ventricular stimulation with a single premature beat delivered at the 
right ventricular apex. After the third beat of tachycardia, the rhythm changed 
from WCT with left BBB morphology to a narrow complex tachycardia. On EP 
testing, this tachycardia was found to represent an orthodromic atrioventricular 
reciprocating   tachycardia   using   a   concealed   left   atrioventricular   free-wall 
accessory   pathway   for   its   retrograde   limb.   The   accessory   pathway   was 
successfully ablated, and the tachycardia could no longer be induced. The clue to 
the diagnosis of SVT with aberrance in this case is the presence of both narrow 
and wide complex tachycardias at nearly the same cycle lengths in the same 
patient. Paper speed is 75 mm/s. 
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            Most patients do not have spontaneous episodes of tachycardia during EP testing and 
have to be induced into the abnormal rhythm by burst pacing or premature stimulation at various 
sites and cycle lengths, with and without b-adrenergic stimulation. It is important however to 
make sure that the arrhythmia induced is the clinical arrhythmia responsible for the patient's 
presentation. This is achieved by careful comparison of the morphology and rate of the induced 
tachycardia with those of prior recordings obtained by ECG, holter monitors, or event monitors. 
Complete electrophysiologic testing is usually necessary not only to differentiate between VT 
and SVT but also to distinguish between the various forms of these arrhythmias.         
            As mentioned before, AV dissociation is the hallmark of ventricular tachycardia. The 
difficulty arises when patients have retrograde 1:1 VA activation during VT. This can be 
difficult to distinguish from an SVT. In this situation, recording a His bundle electrogram and 
analyzing its relationship to the atrial and ventricular electrograms is essential for establishing 
the diagnosis. Also, performing electrophysiologic and pharmacologic maneuvers to try to 
dissociate the atria from the ventricles can be of great help.                                             
Management   of   Wide   Complex   Tachycardia                                                    
            The initial approach to the management of the patient who presents with WCT depends 
primarily on the patient's hemodynamic status. Patients with low blood pressure, pulmonary 
edema, severe angina, or other evidence of poor perfusion associated with the WCT should be 
promptly cardioverted back into normal rhythm, using synchronized electrical direct current. 
Hitting the patient on the chest, also called "thump version" can sometimes terminate a WCT 
presumably by mechanically inducing a premature ventricular complex that interrupts the 
reentrant   circuit   of   the   tachycardia.                                                            
            For the hemodynamically stable patient, time should be spent on analyzing data from the 
history, physical examination, and ECG recordings to reach a diagnosis with a high degree of 
confidence. As mentioned above, from a statistical standpoint, the most likely diagnosis in 
patients with WCT is VT. Assuming this diagnosis even in the hemodynamically stable patient 
until proven otherwise is the safest approach to management.                                         
            Because it can terminate both SVT and VT, Amiodarone (class III) is the agent of choice 
for stable WCT particularly if the etiology is uncertain. It is also particularly useful in patients 
with poor ejection fraction, since it has a favorable hemodynamic profile.24 Procainamide (Class 
IA) can also be used in the initial treatment of hemodynamically stable WCT. Its main 
disadvantage is that it cannot be administrated rapidly secondary to hypotension. Lidocaine (IB) 
is very useful for VT of ischemic origin. It does not terminate SVT, however, and can result in 
confusion at high doses. Adenosine is a useful diagnostic and therapeutic medication when a 
diagnosis of SVT is suspected. It works by blocking conduction through the AV node, which is 
an essential part of the tachycardia circuit in most SVTs. It can at times terminate automatic 
atrial tachycardias and rare adenosine-sensitive VTs. Because of its very short half-life, it rarely 
causes complications in patients with WCT. An exception to this general rule is in the patient 
who presents with irregular WCT due to atrial fibrillation and preexcitation over a manifest 
accessory pathway. In this instance, adenosine can block conduction through the AV node and 
favor conduction of atrial fibrillation wavelets down the bypass tract, possibly leading to 
ventricular   fibrillation.                                                                                        
            After the acute management of an episode of WCT, long-term plans should be made to 
prevent the recurrence of the episodes, minimize their symptomatic impact, and protect the 
patient against sudden cardiac death. In general, the therapeutic options include pharmacological 
treatment   with   anti-arrhythmic   drugs,   device   treatment   with   the   automatic   implantable 
cardioverter-defibrillator, and catheter ablation procedures. A combination of two or more of 
these   modalities   is   sometimes   necessary.                                                        
             In the patient with SVT, a catheter-based approach to therapy is curative in the 
overwhelming majority of patients and provides protection against sudden cardiac death in 
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patients with the Wolf-Parkinson-White syndrome who have a rapidly conducting antegrade 
accessory pathway. In those patients whose ablation procedure fails or who choose not to 
undergo an invasive test, numerous antiarrhythmic medications can be used to suppress the SVT 
including b-blockers, calcium channel blockers, or class I and class III anti-arrhythmic drugs.
             In patients with poor ejection fraction and sustained ventricular tachycardia, device 
therapy is usually recommended. Pharmacologic therapy is used as an adjunctive therapy to 
minimize the episodes of VT and prevent defibrillator shocks. Occasionally, catheter ablation is 
needed as an adjunctive therapy for frequent or incessant VTs that fail to respond to medications.
            Not all VTs, however, are life-threatening and require device therapy. Idiopathic VTs 
occur in structurally normal hearts and carry a very good prognosis. These include right and left 
ventricular outflow tract VTs and left ventricular fascicular (verapamil-sensitive) VTs. Like 
SVTs, idiopathic VTs can also be cured with catheter ablation with good success rates.25,26 
Summary
             Patients who present with WCT constitute a challenge to the diagnostic acumen of 
physicians. If misdiagnosed, these patients can be mismanaged, which can lead to lethal 
consequences. In the hemodynamically unstable patient, synchronized electrical cardioversion is 
the initial therapy. In the stable patient, physicians should use all clues provided by the history, 
physical examination, and ECG, in reaching the correct diagnosis. Until proven otherwise, any 
WCT should be managed as if it were VT, in keeping with the consideration of "First, do no 
harm". This implies that physicians should refrain from using long acting AV nodal blocking 
agents   that   can   induce   hypotension   in   an   otherwise   stable   patient.
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